Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Morin

Showing results (411-420 of 512) with videos related to

Pageof 52
Sort By:
The Journal of Molecular Diagnostics : JMD|November 26, 2018
A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical SpecimensMiguel Alcaide, Matthew Cheung, Kevin Bushell, et al.
Blood|March 6, 2013
Analysis of FOXO1 mutations in diffuse large B-cell lymphomaDiane L Trinh, David W Scott, Ryan D Morin, et al.
Oncotarget|November 8, 2012
Recurrent targets of aberrant somatic hypermutation in lymphomaAlireza Hadj Khodabakhshi, Ryan D Morin, Anthony P Fejes, et al.
Oncotarget|May 26, 2016
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutationsChenglin Wu, Noel Fcc de Miranda, Longyun Chen, et al.
European Journal of Pharmacology|July 23, 1997
Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptorsY Ala, D Morin, E Mahé, et al.
The Journal of Clinical Investigation|November 3, 2010
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapyLeandro C Cerchietti, Katerina Hatzi, Eloisi Caldas-Lopes, et al.
Blood|June 9, 2016
Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomasLauren C Chong, David D W Twa, Anja Mottok, et al.
Leukemia & Lymphoma|January 4, 2018
The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samplesClaudia M Wever, Dominique Geoffrion, Bruno M Grande, et al.
Cancer Immunology Research|December 29, 2025
The CCL17-CCR4 axis is critical for mutant STAT6-mediated microenvironmental remodelling and therapeutic resistance in Relapsed/Refractory Diffuse Large B-cell LymphomaMadelyn J Abraham, Cynthia Guilbert, Natascha Gagnon, et al.
Diabetes, Obesity & Metabolism|November 21, 2015
One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromesC Vatier, S Fetita, P Boudou, et al.
Pageof 52

Showing results (411-420 of 512) with videos related to

Sort By:
Pageof 52
The Journal of Molecular Diagnostics : JMD|November 26, 2018
A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical SpecimensMiguel Alcaide, Matthew Cheung, Kevin Bushell, et al.
Blood|March 6, 2013
Analysis of FOXO1 mutations in diffuse large B-cell lymphomaDiane L Trinh, David W Scott, Ryan D Morin, et al.
Oncotarget|November 8, 2012
Recurrent targets of aberrant somatic hypermutation in lymphomaAlireza Hadj Khodabakhshi, Ryan D Morin, Anthony P Fejes, et al.
Oncotarget|May 26, 2016
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutationsChenglin Wu, Noel Fcc de Miranda, Longyun Chen, et al.
European Journal of Pharmacology|July 23, 1997
Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptorsY Ala, D Morin, E Mahé, et al.
The Journal of Clinical Investigation|November 3, 2010
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapyLeandro C Cerchietti, Katerina Hatzi, Eloisi Caldas-Lopes, et al.
Blood|June 9, 2016
Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomasLauren C Chong, David D W Twa, Anja Mottok, et al.
Leukemia & Lymphoma|January 4, 2018
The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samplesClaudia M Wever, Dominique Geoffrion, Bruno M Grande, et al.
Cancer Immunology Research|December 29, 2025
The CCL17-CCR4 axis is critical for mutant STAT6-mediated microenvironmental remodelling and therapeutic resistance in Relapsed/Refractory Diffuse Large B-cell LymphomaMadelyn J Abraham, Cynthia Guilbert, Natascha Gagnon, et al.
Diabetes, Obesity & Metabolism|November 21, 2015
One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromesC Vatier, S Fetita, P Boudou, et al.
Pageof 52